Multiple myositis-specific autoantibodies in dermatomyositis: 2 cases and review of the literature

Multiple myositis-specific autoantibodies in dermatomyositis: 2 cases and review of the literature

Bibliographic Details
Main Authors:	Neha Narayan, BA, Christopher T. Richardson, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2022-07-01
Series:	JAAD Case Reports
Subjects:	antinuclear helicase protein anti-SUMO–activating enzyme anti-transcriptional intermediary factor 1-γ dermatomyositis Mi-2 SAE-1
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512622002302

Similar Items

Prominent dyspigmentation in a patient with dermatomyositis and TIF1-γ autoantibodies
by: Daniel Gutierrez, MD, et al.
Published: (2022-04-01)

Myositis-specific antibodies in dermatomyositis: A single-center experience of 33 cases in Taiwan
by: Wei-Ting Liu, et al.
Published: (2023-01-01)

Genetic background may contribute to the latitude-dependent prevalence of dermatomyositis and anti-TIF1-γ autoantibodies in adult patients with myositis
by: Joanna E. Parkes, et al.
Published: (2018-06-01)

Anti-transcriptional intermediary factor-1γ antibody-positive dermatomyositis in a patient with triple-negative breast cancer treated with adjuvant capecitabine
by: Alaina J. Kessler, MD, MPH, et al.
Published: (2023-05-01)

Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis
by: Suo Zhang, et al.
Published: (2022-02-01)

AC-X: Characteristic Antinuclear Antibody Patterns of Two Anti-Mi-2 Autoantibody-Positive Dermatomyositis Patients—A Case Report
by: Ziyan Wu, et al.
Published: (2022-03-01)

Clinical profile of anti-transcription intermediary factor-1 gamma-positive adults from a single tertiary care center
by: Avanish Jha, et al.
Published: (2022-01-01)

Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report
by: Takayuki Kishi, et al.
Published: (2021-03-01)

A Case of Dermatomyositis with Esophageal Fistula in Whom Blind Mucosal Biopsy Detected Occult Oropharyngeal Carcinoma
by: Miho Kabuto, et al.
Published: (2014-11-01)

Panniculitis in dermatomyositis: Two cases with antitranscriptional intermediary factor‐1 antibody as myositis‐specific antibody and review of the literature
by: Kaori Takezawa, et al.
Published: (2022-06-01)

Clinical Characteristics of Anti-TIF-1γ Antibody-Positive Dermatomyositis Associated with Malignancy
by: Yumi Harada, et al.
Published: (2022-03-01)

Bench to bedside review of myositis autoantibodies
by: Boaz Palterer, et al.
Published: (2018-03-01)

First report of anti-TIF1γ dermatomyositis in a patient with myelodysplastic syndrome
by: B. Palterer, et al.
Published: (2017-08-01)

Paraneoplastic dermatomyositis appearing after nivolumab therapy for gastric cancer: a case report
by: Chikako Shibata, et al.
Published: (2019-06-01)

Transcriptional intermediary factor 1 (TIF1) and anti-TIF1γ antibody-positive dermatomyositis
by: Yorihisa Kotobuki, et al.
Published: (2021-01-01)

SCLC, Paraneoplastic Dermatomyositis, Positive Transcription Intermediary Factor 1-γ, and Point Mutation in the Transcription Intermediary Factor 1-γ Coding Gene: A Case Report
by: Johnathan Arnon, MD, et al.
Published: (2021-09-01)

Clinical Features and Cutaneous Manifestations of Juvenile and Adult Patients of Dermatomyositis Associated with Myositis-Specific Autoantibodies
by: Naoko Okiyama
Published: (2021-04-01)

Comparative analysis of immunotherapy responses in small cell lung cancer patients with dermatomyositis
by: So‐yun Kim, et al.
Published: (2024-03-01)

Symptomatic macroglossia and tongue myositis in Dermatomyositis
by: Ajili Faida, et al.
Published: (2013-04-01)

Demyelinating polyneuropathy, dermatomyositis, and interstitial pneumonitis associated with autoantibody against melanoma differentiation-associated gene 5
by: Yu-Hsiang Chiu, et al.
Published: (2017-01-01)

Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis
by: Marcela Gran Pina Cruellas, et al.
Published: (2013-07-01)

Immune checkpoint inhibitor therapy in a patient with small cell lung cancer and anti‐transcriptional intermediary factor 1‐γ antibody‐positive dermatomyositis: A case report
by: Yoonjoo Kim, et al.
Published: (2022-10-01)

Myositis Specific Autoantibodies: A Clinical Perspective
by: Alenzi FM
Published: (2020-01-01)

Calcinosis cutis causing cutaneous ulceration and secondary bacterial infection in a patient with antinuclear matrix protein 2 antibody–positive dermatomyositis
by: Ryuichi Takimiya, et al.
Published: (2022-01-01)

Antibodies against Small Ubiquitin-like Modifier Activating Enzyme May Be a Protective Factor from Rapid Progressive Interstitial Lung Disease in Patients Bearing Antibodies against Melanoma Differentiation Associated Gene 5
by: Hung-Cheng Tsai, et al.
Published: (2024-01-01)

Clinical and autoantibody phenotypes of juvenile dermatomyositis
by: Oksana Boyarchuk, et al.
Published: (2022-08-01)

Anti-MDA5 antibody-positive dermatomyositis with severe cutaneous ulcers
by: Büşra Demirbağ Gül, et al.
Published: (2022-12-01)

Clinical Characteristics of Dermatomyositis with Interstitial Lung Disease: A Retrospective Case–Control Study
by: Chenghua Weng, et al.
Published: (2023-02-01)

Is Anti-NXP2 Autoantibody a Risk Factor for Calcinosis and Poor Outcome in Juvenile Dermatomyositis Patients? Case Series
by: Natasa Toplak, et al.
Published: (2022-02-01)

Overlap syndrome of type Wong variant dermatomyositis and rheumatoid arthritis
by: Yen-Jen Wang, et al.
Published: (2014-03-01)

Type 1 interferon signature in peripheral blood mononuclear cells and monocytes of idiopathic inflammatory myopathy patients with different myositis-specific autoantibodies
by: Mengdi Li, et al.
Published: (2023-05-01)

The relevance of anti-Jo-1 autoantibodies in patients with definite dermatomyositis
by: Vanessa Posener de Andrade, et al.
Published: (2021-02-01)

Neutrophil-to-lymphocyte ratio is a predictive marker for anti-MDA5 positive dermatomyositis
by: Tao Liu, et al.
Published: (2022-08-01)

Presence of autoantibodies and epidemiological characteristics of systemic sclerosis patients in western Paraná
by: Alana Rubia Balbinot, et al.
Published: (2022-10-01)

Wong-type dermatomyositis with interstitial lung disease and anti-SRP and -PM/Scl antibodies treated with intravenous immunoglobulin
by: Eric H. Kowalski, MD, et al.
Published: (2023-11-01)

Comparison of cytokine/chemokine profiles between dermatomyositis and anti-synthetase syndrome
by: Yikang Wang, et al.
Published: (2022-12-01)

Treatment of MDA5-positive dermatomyositis complicated by gangrenous cholecystitis with tofacitinib
by: Man Luo, et al.
Published: (2022-05-01)

Not all autoantibodies are clinically relevant. Classic and novel autoantibodies in Sjögren’s syndrome: A critical review
by: Francisco Vílchez-Oya, et al.
Published: (2022-10-01)

Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort
by: Fang Chen, et al.
Published: (2022-05-01)

Rapidly progressive interstitial lung disease combined with pneumocystis jiroveci pneumonia in a patient with single anti-TIF-1γ antibody positive dermatomyositis in the context of an underlying tumor
by: Hengzhe Zhang, et al.
Published: (2023-07-01)